Status:
COMPLETED
Cognitive Rehabilitation in Post-COVID-19 Syndrome
Lead Sponsor:
University of Missouri-Columbia
Collaborating Sponsors:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Post-COVID-19 Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS...
Detailed Description
Post-COVID-19 symptoms (PCS) cognitive symptoms require the rehabilitation community to investigate ways to: (1) reduce the functional impact of the symptoms on daily life and (2) support individuals ...
Eligibility Criteria
Inclusion
- self-reported cognitive symptoms persisting for at least 6 weeks following COVID-19 infection (Cognitive Failures Questionnaire (CFQ) score \>43)
- self-identified activity performance goals per the Canadian Occupational Performance Measure (COPM)
- documented prior diagnosis of COVID-19
- read, write, and speak English fluently
- ability to provide valid informed electronic consent
Exclusion
- diagnosis of severe neurological or psychiatric condition(s)
- dementia symptoms as indicated by a score of \<23 on the Montreal Cognitive Assessment (MoCA)
- untreated sleep apnea (≥5 on the STOPBANG)
- prior cancer treatment
- severe depressive symptoms (\>21 on the Patient Health Questionnaire-9)
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06136871
Start Date
February 1 2024
End Date
June 30 2025
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Department of Occupational Therapy
Columbia, Missouri, United States, 65211